Oracle (ORCL) PT Raised to $147 at Barclays, 'RPO Strength And Capex Ramp Point To Better Times Ahead'
Get Alerts ORCL Hot Sheet
Price: $130.67 -6.37%
Rating Summary:
48 Buy, 22 Hold, 4 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 14 | Down: 50 | New: 9
Rating Summary:
48 Buy, 22 Hold, 4 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 14 | Down: 50 | New: 9
Join SI Premium – FREE
(Updated - March 12, 2024 4:26 AM EDT)
Barclays analyst Raimo Lenschow raised the price target on Oracle (NYSE: ORCL) to $147.00 (from $140.00) while maintaining a Overweight rating.
The analyst comments "Q3 in itself was a solid quarter for ORCL with slightly better application and infrastructure growth. However, the items investors will more likely focus on are higher Capex this quarter and expected next FY ($2.1bn for Q3 underlying, $10bn for FY25) along with healthy RPO growth as this suggests higher cloud growth ahead."
You May Also Be Interested In
- Evercore ISI Downgrades Reddit (RDDT) to In Line, Removes From Tactical Outperform List
- Freedom Broker Upgrades Mondelez International (MDLZ) to Buy
- Encompass Health Corp (EHC) PT Raised to $155 at Raymond James
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share